[HTML][HTML] Evolving trends in surgical management of breast cancer: an analysis of 30 years of practice changing papers

S Keelan, M Flanagan, ADK Hill - Frontiers in Oncology, 2021 - frontiersin.org
The management of breast cancer has evolved into a multidisciplinary evidence-based
surgical speciality, with emphasis on conservative surgery. A number of landmark trials have …

Global impact of lymphedema on quality of life and society

KM Jaszkul, K Farrokhi, V Castanov… - European Journal of …, 2023 - Springer
Lymphedema is a chronic disorder of the lymphatic system characterized by the
accumulation of interstitial fluid in tissues. It affects millions of individuals worldwide …

Correlation analysis of pathological features and axillary lymph node metastasis in patients with invasive breast cancer

H Chen, X Meng, X Hao, Q Li, L Tian… - Journal of …, 2022 - Wiley Online Library
Objective. To investigate the risk factors of axillary lymph node metastasis in patients with
invasive breast cancer. Methods. This study retrospectively included 122 cases of invasive …

Is axillary staging obsolete in early breast cancer?

M Morrow - Surgical Oncology Clinics, 2023 - surgonc.theclinics.com
Historically, axillary lymph node dissection (ALND) was regarded as part of the curative
management of breast cancer. However, after clinical trials made it clear that ALND did not …

[HTML][HTML] The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer

L Dihge, PO Bendahl, I Skarping, M Hjärtström… - Frontiers in …, 2023 - frontiersin.org
Objective To implement artificial neural network (ANN) algorithms for noninvasive lymph
node staging (NILS) to a decision support tool and facilitate the option to omit surgical …

[HTML][HTML] The NILS study protocol: a retrospective validation study of an artificial neural network based preoperative decision-making tool for noninvasive lymph node …

I Skarping, L Dihge, PO Bendahl, L Huss, J Ellbrant… - Diagnostics, 2022 - mdpi.com
Newly diagnosed breast cancer (BC) patients with clinical T1–T2 N0 disease undergo
sentinel-lymph-node (SLN) biopsy, although most of them have a benign SLN. The pilot …

Axillary ultrasonography for early-stage invasive breast cancer

K Jiang, C Ma, Y Yang, E McKevitt, JS Pao… - The American Journal of …, 2024 - Elsevier
Background Among women with early invasive breast cancer and 1–2 positive sentinel
nodes, sentinel lymph node biopsy (SLNB) is non-inferior to axillary lymph node dissection …

[HTML][HTML] Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1–2 suspicious …

SE Lee, SG Ahn, JH Ji, Y Kook, JS Jang… - Frontiers in …, 2023 - frontiersin.org
Background It is unclear whether upfront surgery or neoadjuvant chemotherapy is
appropriate for first treatment in hormone receptor (HR)-positive human epidermal growth …

Using MammaPrint on core needle biopsy to guide the need for axillary staging during breast surgery

LM Drapalik, ME Miller, L Rock, P Li, A Simpson… - Surgery, 2024 - Elsevier
Background At present, the only opportunity to omit axillary staging is with Choosing Wisely
criteria for women ages> 70 y with cT1 2N0 estrogen receptor–positive/human epidermal …

[HTML][HTML] Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in Women With Breast Cancer≥ 70 Years Old?

GR Daly, GP Dowling, E Hamza, M AlRawashdeh… - Clinical Breast …, 2024 - Elsevier
Background There have been ongoing attempts to de-escalate surgical intervention in older
breast cancer patients in recent years. However, there remains ongoing hesitancy amongst …